Research Topics
Species | Peter HauserSummaryCountry: USA Publications
| Collaborators
|
Detail Information
Publications
A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis CP Hauser
Portland VA Medical Center, Behavioral Health and Neurosciences Division, NW Hepatitis C Field Based Resource Center Oregon Health and Sciences University, Portland, OR 97201, USA
Mol Psychiatry 7:942-7. 2002..SSRIs, in particular citalopram, are an effective treatment for IFN-induced depression in HCV patients...- Antiviral completion rates and sustained viral response in hepatitis C patients with and without preexisting major depressive disorderPeter Hauser
Northwest Hepatitis C Resource Center, Portland VA Medical Center, Portland, OR 97202, USA
Psychosomatics 50:500-5. 2009..Despite evidence suggesting that the majority of patients with hepatitis C virus (HCV) have psychiatric and substance use disorders, patients with these comorbidities have historically been excluded from antiviral therapy for HCV... - Antiviral therapy completion and response rates among hepatitis C patients with and without schizophreniaMarilyn Huckans
Department of Psychiatry, Oregon Health and Science University, Portland, Oregon, USA
Schizophr Bull 36:165-72. 2010..Despite disproportionately high rates of hepatitis C (HCV) among patients with severe mental illness, to date, there is scant empirical data available regarding antiviral therapy outcomes within this population... - The influence of antiviral therapy on psychiatric symptoms among patients with hepatitis C and schizophreniaMarilyn Huckans
Northwest Hepatitis C Resource Center, Portland VA Medical Center, Portland, OR, USA
Antivir Ther 15:111-9. 2010..The aim of this study was to determine whether antiviral therapy is associated with higher rates of psychiatric symptoms in patients with schizophrenia (SCHZ)... - Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disordersMarilyn S Huckans
Northwest Hepatitis C Resource Center, Portland VA Medical Center, Portland, USA
Subst Abuse Treat Prev Policy 2:4. 2007.... - Prophylactic antidepressant treatment in patients with hepatitis C on antiviral therapy: a double-blind, placebo-controlled trialBenjamin J Morasco
Behavioral Health and Clinical Neurosciences Division, Portland VA Medical Center, Portland, OR 97239, USA
Psychosomatics 51:401-8. 2010..Approximately one-third of patients undergoing interferon-? (IFN-?) therapy for treatment of the hepatitis C virus (HCV) develop major depression, which decreases functioning and may lead to the reduction or discontinuation of treatment... - Predictors of pain intensity and pain functioning in patients with the hepatitis C virusBenjamin J Morasco
Northwest Hepatitis C Resource Center and Mental Health and Clinical Neurosciences Division, Portland VA Medical Center, Portland, OR 97239, USA
Gen Hosp Psychiatry 32:413-8. 2010..To examine the relationships among biological and psychological variables with pain intensity and pain functioning in patients with the hepatitis C virus (HCV)... - Depression comorbidity and antidepressant use in veterans with chronic hepatitis C: results from a retrospective chart reviewJulie A Nelligan
Northwest Hepatitis C Resource Center, Behavioral Health and Clinical Neurosciences Division, Portland Department of Veterans Affairs VA Medical Center, Oregon Health and Science University, Portland, Oregon 97207, USA
J Clin Psychiatry 69:810-6. 2008..In this study we characterize the prevalence and severity of co-morbid depression, as well as antidepressant and other psychotropic prescribing patterns, in a sample of U.S. veterans with HCV... - Relapse to opioid use after treatment of chronic hepatitis C with pegylated interferon and ribavirinAnnette M Matthews
Portland VA Medical Center, 3710 S.W. U.S. Veteran Hospital Rd, P.O. Box 1035 (V3MHC, Portland, OR 97202, USA
Am J Psychiatry 163:1342-7; quiz 1479. 2006 - Management of hepatitis C disease among VA patients with schizophrenia and substance use disordersMarilyn S Huckans
Northwest Hepatitis C Resource Center, Portland Veterans Affairs Medical Center, and Department of Psychiatry at Oregon Health and Science University 97239, USA
Psychiatr Serv 57:403-6. 2006.... - The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorderMarilyn Huckans
Northwest Hepatitis C Resource Center, Portland VA Medical Center, Portland, Oregon 97239, USA
J Int Neuropsychol Soc 15:69-82. 2009..Results indicate that chronic HCV is associated with cognitive impairment in the absence of a history of SUD. The most robust deficits appear to be in verbal learning and reasoning/mental flexibility. (JINS, 2009, 15, 69-82.)... - Pain, substance use disorders and opioid analgesic prescription patterns in veterans with hepatitis CAshlee J Whitehead
Northwest Hepatitis C Resource Center, Portland, OR, USA
J Pain Symptom Manage 36:39-45. 2008..13.4 days, P<0.001). These data demonstrate that pain and SUD diagnoses were common among HCV+ patients, and that opioids were frequently prescribed. Co-occurring SUD was not associated with indicators of prescription opioid misuse... - Psychiatric and substance use disorders comorbidities in veterans with hepatitis C virus and HIV coinfectionBret E Fuller
Mental Health Division, Portland Veterans Affairs Medical Center, Portland, Oregon 97210, USA
Curr Opin Psychiatry 22:401-8. 2009..This review covers timely research relative to comorbid conditions that are common in this population including psychiatric diagnoses, substance use disorders and neurocognitive problems... - Prevalence of liver disease in veterans with bipolar disorder or schizophreniaBret E Fuller
Portland Veterans Affairs Medical Center, Portland, OR 97210, USA
Gen Hosp Psychiatry 33:232-7. 2011..To assess the prevalence of three liver diseases [hepatitis C virus (HCV), nonalcoholic fatty liver disease and alcohol-induced cirrhosis] in patients (veterans) with/without schizophrenia/schizoaffective disorder and bipolar disorder... - Screening for depression in patients with hepatitis C using the Beck Depression Inventory-II: do somatic symptoms compromise validity?Alexander L Patterson
Mental Health and Clinical Neurosciences Division, Portland VA Medical Center, Portland, OR, USA
Gen Hosp Psychiatry 33:354-62. 2011..The objective of the study was to evaluate the validity of the Beck Depression Inventory-II (BDI-II) when used to measure depression in patients with hepatitis C virus (HCV)... - Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and managementJennifer M Loftis
Department of Psychiatry, Oregon Health and Science University, Portland, Oregon, USA
Drugs 66:155-74. 2006.... - Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disordersAnnette M Matthews
Northwest Hepatitis C Resource Center, and Behaviorual Health and Clinical Neurosciences Division, Portland VA Medical Center, Portland, OR 97202, USA
Bipolar Disord 10:266-70. 2008..Our hypothesis was that HCV antibody testing rates and HCV prevalence would be higher in the BD, SUD, and DD groups than the control group... - Integrated hepatitis C virus treatment: addressing comorbid substance use disorders and HIV infectionMarilyn S Huckans
Northwest Hepatitis C Resource Center, Portland VA Medical Center, Portland, OR 97239, USA
AIDS 19:S106-15. 2005..Increased infection rates among patients with SUD also warrant integration of HCV and HIV screening and testing into mental health and addiction programmes... - Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of careMarian Fireman
Northwest Hepatitis C Resource Center and Behavioral Health and Neurosciences Division, Portland, OR 97239, USA
Clin Infect Dis 40:S286-91. 2005..Comanagement treatment models involving mental health care may expand the pool of patients eligible to receive treatment with IFN, as well as enhance treatment outcomes... - Association of interferon-alpha-induced depression and improved treatment response in patients with hepatitis CJennifer M Loftis
Portland VA Medical Center, Behavioral Health and Clinical Neurosciences Division, OR, USA
Neurosci Lett 365:87-91. 2004..In conclusion, our findings suggest that IFN-alpha-induced MDD may be a predictor of a positive response to IFN-alpha therapy, or an indication of optimal dosing... - Administration of pegylated interferon-alpha-2a or -2b does not induce sickness behavior in Lewis ratsJennifer M Loftis
Behavioral Health and Clinical Neurosciences Division, Portland VA Medical Center, 3710 SW US Veteran s Hospital Road, Portland, OR 97239, USA
Psychoneuroendocrinology 31:1289-94. 2006..Collectively, our data suggest that Lewis rats are likely not a useful model to study IFN-induced depression... - The phenomenology and treatment of interferon-induced depressionJennifer M Loftis
Behavioral Health and Clinical Neurosciences Division, Portland VA Medical Center, Portland, OR, USA
J Affect Disord 82:175-90. 2004..Screening and monitoring, ideally using symptom rating scales for depression, and early antidepressant treatment intervention appear necessary to optimize IFN therapy for the majority of patients... - Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alphaJennifer M Loftis
Behavioral Health and Clinical Neurosciences Division, Portland VA Medical Center, Department of Psychiatry, Oregon Health and Science University, Portland, OR 97239, USA
Neurosci Lett 430:264-8. 2008..Future studies should investigate how inflammatory mediators play a role in the expression of specific depressive symptoms in patients with chronic infection. Patients with HCV represent an interesting model to examine this relationship... - Treatment outcomes in depression: comparison of remote treatment through telepsychiatry to in-person treatmentPaul E Ruskin
VA Capitol Network Mental Illness Research Education and Clinical Center, Baltimore, MD, USA
Am J Psychiatry 161:1471-6. 2004.... - Appreciation of research information in patients with bipolar disorderSahana Misra
Portland Veterans Affairs Medical Center, Portland, OR, USA
Bipolar Disord 10:635-46. 2008..We compared the abilities of euthymic and manic bipolar patients to appreciate and make voluntary decisions regarding research participation... - Psychiatric management of the hepatitis C patientMuhamad Aly Rifai
Northwest Hepatitis C Resource Center, Portland VA Medical Center, Behavioral Health and Clinical Neurosciences Division, PO Box 1034 P3MHADM, Portland, OR 97239, USA
Curr Treat Options Gastroenterol 9:508-19. 2006..In this review, we discuss the process of pretreatment assessment of patients with HCV and psychiatric illness and specifically address IFN- and RBV-induced depression in patients receiving HCV treatment... - Neuropsychiatric side effects of HCV therapy and their treatment: focus on IFN alpha-induced depressionPeter Hauser
Oregon Health Science University, and Behavioral Health and Clincial Neurosciences Division, Portland VA Medical Center, 97239, USA
Gastroenterol Clin North Am 33:S35-50. 2004....